Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China · Delayed Price · Currency is CNY 12.49
-0.44 (-3.40%)
Nov 13, 2026, 3:00 PM CST
SHA:600513 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 227.72 | 349.09 | 227.72 | 281.38 | 330.65 | 330.69 |
Cash & Short-Term Investments | 227.72 | 349.09 | 227.72 | 281.38 | 330.65 | 330.69 |
Cash Growth | -15.29% | 53.30% | -19.07% | -14.90% | -0.01% | 36.73% |
Accounts Receivable | 731.66 | 729.98 | 593.41 | 585.63 | 575.95 | 517.71 |
Other Receivables | 44.67 | 84.27 | 69.39 | 28.17 | 14.74 | 17.06 |
Receivables | 776.33 | 814.25 | 662.81 | 613.8 | 590.69 | 534.77 |
Inventory | 637.85 | 660.68 | 439.32 | 315.45 | 279.39 | 202.59 |
Other Current Assets | 273.27 | 162.11 | 148.22 | 142.77 | 167.83 | 134.29 |
Total Current Assets | 1,915 | 1,986 | 1,478 | 1,353 | 1,369 | 1,202 |
Property, Plant & Equipment | 1,548 | 1,475 | 1,210 | 1,151 | 1,006 | 849.99 |
Long-Term Investments | 9.82 | 6.01 | 2.59 | 11.64 | 2.93 | 4.62 |
Goodwill | 62.5 | 62.5 | 21.07 | 21.07 | 21.07 | 21.07 |
Other Intangible Assets | 229.84 | 231.17 | 100.94 | 101.32 | 88.17 | 76.98 |
Long-Term Deferred Tax Assets | 36.5 | 35.82 | 22.13 | 23.34 | 20.57 | 7.62 |
Long-Term Deferred Charges | 329.82 | 250.89 | 160.79 | 41.37 | 41.49 | 45.92 |
Other Long-Term Assets | 35.4 | 49.49 | 24.21 | 152.69 | 166.33 | 146.25 |
Total Assets | 4,167 | 4,097 | 3,019 | 2,856 | 2,715 | 2,355 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 497.72 | 570.95 | 351.32 | 263.38 | 248.11 | 227.96 |
Accrued Expenses | 16.11 | 61.58 | 57.32 | 75.53 | 74.13 | 46.26 |
Short-Term Debt | 917.05 | 958.59 | 697.72 | 591.76 | 590.63 | 504.55 |
Current Portion of Long-Term Debt | 318.15 | 229.33 | 98.05 | 30.4 | 49.41 | 4.17 |
Current Portion of Leases | - | 1.51 | 1.16 | 0.71 | - | - |
Current Income Taxes Payable | 30.78 | 7.33 | 4.88 | 9.14 | 10.26 | 5.55 |
Current Unearned Revenue | 27.78 | 56.74 | 38.3 | 27.13 | 29.07 | 21.82 |
Other Current Liabilities | 150.09 | 142.61 | 91.01 | 248.46 | 242.22 | 207.02 |
Total Current Liabilities | 1,958 | 2,029 | 1,340 | 1,247 | 1,244 | 1,017 |
Long-Term Debt | 505.89 | 355.09 | 80 | 79 | 49.65 | 49.9 |
Long-Term Leases | 4.09 | 5.18 | 6.39 | 3.91 | - | - |
Long-Term Unearned Revenue | 13.39 | 12.24 | 11.34 | 3.93 | 2.35 | 2.65 |
Long-Term Deferred Tax Liabilities | 14.59 | 15.92 | 4.75 | 4.43 | 5.01 | 3.93 |
Other Long-Term Liabilities | - | - | - | 0.59 | 0.37 | 0.07 |
Total Liabilities | 2,496 | 2,417 | 1,442 | 1,338 | 1,301 | 1,074 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 285.46 | 285.46 | 285.46 | 285.46 | 287.15 | 287.99 |
Additional Paid-In Capital | 259.94 | 259.94 | 259.94 | 259.94 | 268.94 | 268.64 |
Retained Earnings | 721.27 | 726.59 | 850.33 | 808.99 | 717.05 | 611.57 |
Treasury Stock | - | - | - | - | -6.51 | -10.09 |
Comprehensive Income & Other | -0.15 | -0.24 | -0.12 | -0.2 | - | - |
Total Common Equity | 1,267 | 1,272 | 1,396 | 1,354 | 1,267 | 1,158 |
Minority Interest | 404.43 | 408.01 | 181.61 | 163.12 | 147.11 | 122.81 |
Shareholders' Equity | 1,671 | 1,680 | 1,577 | 1,517 | 1,414 | 1,281 |
Total Liabilities & Equity | 4,167 | 4,097 | 3,019 | 2,856 | 2,715 | 2,355 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,745 | 1,550 | 883.33 | 705.78 | 689.69 | 558.63 |
Net Cash (Debt) | -1,517 | -1,201 | -655.61 | -424.4 | -359.05 | -227.93 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -5.23 | -4.15 | -2.26 | -1.48 | -1.24 | -0.79 |
Filing Date Shares Outstanding | 353.49 | 285.46 | 285.46 | 285.46 | 287.15 | 287.99 |
Total Common Shares Outstanding | 353.49 | 285.46 | 285.46 | 285.46 | 287.15 | 287.99 |
Working Capital | -42.53 | -42.51 | 138.3 | 106.88 | 124.73 | 185.02 |
Book Value Per Share | 3.58 | 4.46 | 4.89 | 4.74 | 4.41 | 4.02 |
Tangible Book Value | 974.17 | 978.07 | 1,274 | 1,232 | 1,157 | 1,060 |
Tangible Book Value Per Share | 2.76 | 3.43 | 4.46 | 4.32 | 4.03 | 3.68 |
Buildings | - | 813.26 | 629 | 517.38 | 516.88 | 381.24 |
Machinery | - | 901.78 | 658.82 | 539.58 | 514.41 | 341.36 |
Construction In Progress | - | 84.34 | 100.22 | 225.81 | 68.31 | 184.84 |